Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 5
1981 8
1982 37
1983 17
1984 26
1985 19
1986 23
1987 29
1988 32
1989 39
1990 39
1991 59
1992 74
1993 77
1994 103
1995 129
1996 109
1997 143
1998 215
1999 222
2000 206
2001 225
2002 243
2003 242
2004 234
2005 267
2006 231
2007 249
2008 257
2009 252
2010 256
2011 266
2012 278
2013 235
2014 280
2015 289
2016 290
2017 300
2018 309
2019 302
2020 369
2021 379
2022 344
2023 325
2024 357
2025 381
2026 299

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,309 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. O'Byrne PM, et al. N Engl J Med. 2018 May 17;378(20):1865-1876. doi: 10.1056/NEJMoa1715274. N Engl J Med. 2018. PMID: 29768149 Free article. Clinical Trial.
Patients were randomly assigned to one of three regimens: twice-daily placebo plus terbutaline (0.5 mg) used as needed (terbutaline group), twice-daily placebo plus budesonide-formoterol (200 mug of budesonide and 6 mug of formoterol) used as needed (budesonide …
Patients were randomly assigned to one of three regimens: twice-daily placebo plus terbutaline (0.5 mg) used as needed (terbutaline group), …
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
Bateman ED, Reddel HK, O'Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM. Bateman ED, et al. N Engl J Med. 2018 May 17;378(20):1877-1887. doi: 10.1056/NEJMoa1715275. N Engl J Med. 2018. PMID: 29768147 Free article. Clinical Trial.
Patients were randomly assigned to receive twice-daily placebo plus budesonide-formoterol (200 mug of budesonide and 6 mug of formoterol) used as needed or budesonide maintenance therapy with twice-daily budesonide (200 mug) plus terbutaline (0.5 mg) u …
Patients were randomly assigned to receive twice-daily placebo plus budesonide-formoterol (200 mug of budesonide and 6 mug of …
Acute pancreatitis in an ulcerative colitis patient treated with vedolizumab and budesonide.
Ravn CD, Bendix M, Lyhne S. Ravn CD, et al. Ugeskr Laeger. 2024 May 27;186(22):V01240025. doi: 10.61409/V01240025. Ugeskr Laeger. 2024. PMID: 38847300 Free article. Danish.
Vedolizumab is a human monoclonal antibody with gut-selective integrin antagonist effect, and it is used for treatment of inflammatory bowel disease (IBD). Budesonid is a glucocorticoid which is released in the colon and it is also used in IBD treatment. This is a case rep …
Vedolizumab is a human monoclonal antibody with gut-selective integrin antagonist effect, and it is used for treatment of inflammatory bowel …
Topical therapy.
Gross V. Gross V. Dig Dis. 2012;30 Suppl 3:92-9. doi: 10.1159/000342730. Epub 2013 Jan 3. Dig Dis. 2012. PMID: 23295698 Review.
Rectal mesalazine is more effective than rectal systemically active corticosteroids or topically active corticosteroids like budesonide. In patients with mild to moderately active distal ulcerative colitis, topical mesalazine is therefore the treatment of choice. ...In the …
Rectal mesalazine is more effective than rectal systemically active corticosteroids or topically active corticosteroids like budesonide …
Budesonide modified-release capsules.
Baker DE. Baker DE. Rev Gastroenterol Disord. 2001;1(3):147-55. Rev Gastroenterol Disord. 2001. PMID: 12120182 Review.
Budesonide modified-release capsule is an effective form of therapy for the treatment of Crohn's disease located in the distal ileum, ileocecal region, and ascending colon. ...Budesonide is equal to less effective than prednisolone or prednisone therapy in the treat …
Budesonide modified-release capsule is an effective form of therapy for the treatment of Crohn's disease located in the distal ileum, …
Exploring the molecular mechanism of budesonide enteric capsules in the treatment of IgA nephropathy based on bioinformatics.
Lin M, Chen S, Chen Y, Gao Q. Lin M, et al. Sci Rep. 2025 Aug 21;15(1):30795. doi: 10.1038/s41598-025-16380-z. Sci Rep. 2025. PMID: 40841751 Free PMC article.
IgA nephropathy (IgAN) is a prevalent primary glomerular disease and a major contributor to end-stage renal disease (ESRD). Budesonide Enteric Capsules (Nefecon ) are the first treatment approved by the U.S. Food and Drug Administration (FDA) targeting galactose-deficient …
IgA nephropathy (IgAN) is a prevalent primary glomerular disease and a major contributor to end-stage renal disease (ESRD). Budesonide …
Asthma: Budesonid sammelt Punkte.
Heppner HJ, Dovjak P. Heppner HJ, et al. MMW Fortschr Med. 2019 Nov;161(19):33. doi: 10.1007/s15006-019-1054-y. MMW Fortschr Med. 2019. PMID: 31691226 German. No abstract available.
[Budesonide].
Schäkel K, Fuchs T. Schäkel K, et al. Dtsch Med Wochenschr. 1995 Oct 27;120(43):1490. Dtsch Med Wochenschr. 1995. PMID: 7588014 German. No abstract available.
Inhaled budesonide/formoterol combination.
McGavin JK, Goa KL, Jarvis B. McGavin JK, et al. Drugs. 2001;61(1):71-8; discussion 79-80. doi: 10.2165/00003495-200161010-00007. Drugs. 2001. PMID: 11217872 Review.
The administration of combined budesonide/formoterol is effective in improving morning and evening peak expiratory flow rates in adults with persistent asthma. ...The most commonly encountered adverse effects in clinical trials with combination budesonide/formoterol …
The administration of combined budesonide/formoterol is effective in improving morning and evening peak expiratory flow rates in adul …
8,309 results